Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arrowhead Pharmaceuticals
Biotech
Novartis ‘always looking’ for new ways to shuttle drugs to brain
“I don't think you will really ever only have one solution to this problem,” the head of neuroscience at Novartis Biomedical Research told Fierce.
James Waldron
May 28, 2026 8:44am
Madrigal boosts MASH pipeline with $1B biobucks Arrowhead deal
May 5, 2026 10:40am
Arrowhead takes aim at obesity with early gene silencing data
Jan 6, 2026 10:19am
Sarepta shares safety update on DM1 RNA med
Nov 24, 2025 4:00pm
Arrowhead sues Ionis over patent dispute for Tryngolza rival
Sep 11, 2025 11:33am
Novartis aims at alpha-synuclein again with $2.2B Arrowhead deal
Sep 2, 2025 9:55am
